Application of tumor markers in breast cancer diagnosis and prognosis

Abstract

Abstract: Tumor markers have been widely used in diagnosis and prognosis of breast cancer. This article reviews the clinical applications of classic breast cancer biomarkers, such as CA15-3, HER2, ER and PR, and the clinical values of emerging biomarkers of breast cancer. Combined detection with multi-biomarkers has higher sensitivity and specificity than detection with single tumor marker, and will become a trend how breast cancer biomarkers are used in clinical treatment.

Key words: tumor markers, breast cancer, diagnosis, prognosis

CLC Number:

R737.9

[1]	GENG Ruijie. Levels of HMGB1 in peripheral blood and monocyte-derived HMGB1 correlate with disease condition in patients with non-puerperal mastitis [J]. Basic & Clinical Medicine, 2026, 46(6): 855-860.
[2]	TIAN Jiao, TONG Jin. Advances in the diagnosis and treatment of severe interstitial lung disease [J]. Basic & Clinical Medicine, 2026, 46(6): 866-871.
[3]	SONG Yueyang, SHI Yajun, YU Xi, WEN Yingshi, SUN Miao. Cantu syndrome complicated with 22q11.2 duplication syndrome:a case report [J]. Basic & Clinical Medicine, 2026, 46(4): 561-565.
[4]	ZHANG Zhen, YANG Lianren, HU Junkun, ZHANG Wei, LIANG Wei. Value of serum D-dimer in evaluating chemotherapy effect and prognosis in patients with non-small cell lung cancer [J]. Basic & Clinical Medicine, 2026, 46(3): 417-420.
[5]	LIU Zhaoyi, YIN Meiling, WANG Lin, ZHOU Jinyu. Absolute quantification of plasma IgG N-glycopeptides as a biomarker for diagnosis of the early COPD [J]. Basic & Clinical Medicine, 2026, 46(3): 332-338.
[6]	WANG Tianjiao, SONG Yiqin, WANG Jing. Association of MICA and CXCR1 with prognosis in children with severe pneumonia [J]. Basic & Clinical Medicine, 2026, 46(2): 261-266.
[7]	QU Haixin, LIANG Junxia, YUAN Erwei, GAO Hongbo, KUI Xiaohua, GUO Weiping. Levels of TLR4, MIF, IL-1β in umbilical cord blood of children with neonatal respiratory distress syndrome and their relationship with prognosis [J]. Basic & Clinical Medicine, 2026, 46(1): 109-113.
[8]	SUN Yingchun, LI Jianjun, YANG Zaibo, YAN Junhui, LIU Yushuo. Level of serum CHI3L1 and sFlt-1 is correlated with disease severity and prognosis of patients with IgA nephropathy [J]. Basic & Clinical Medicine, 2026, 46(1): 22-27.
[9]	LI Binfeng, LYU Fayou, YI Huijun, LYU Lyu. Advances in the mechanism of action of the ring finger proteins family in breast cancer [J]. Basic & Clinical Medicine, 2026, 46(1): 124-128.
[10]	WEI Jing, SUN Wei. Clinical applications of urine proteome based on mass spectrometry [J]. Basic & Clinical Medicine, 2025, 45(8): 982-991.
[11]	CHEN Lingyun, CHEN Wensong, SUN Qinqiang, ZI Jin. Progress in urinary metabolomics research technologies and applications in cancer diagnosis [J]. Basic & Clinical Medicine, 2025, 45(8): 999-1009.
[12]	WU Haifeng, LI Xiaolong, LI Fang, CHEN Xiaohua, SONG Rui, HAN Xue. Expression of KIF23 in rectal cancer tissues is correlated with prognosis [J]. Basic & Clinical Medicine, 2025, 45(8): 1054-1058.
[13]	LI Nan, ZHANG Guitao, WANG Bin, FENG Yao, LI Shujuan, ZHOU Yinghua. Correlation between inflammatory response-related indicators and poor outcomes of in-hospital patients with symptomatic stroke [J]. Basic & Clinical Medicine, 2025, 45(8): 1083-1087.
[14]	JIN Xiaoxia, LIU Yushan, HU Jiping, ZHU Xinghua. Expression of COA6 in breast cancer and its correlation with tumor immune cell infiltration [J]. Basic & Clinical Medicine, 2025, 45(6): 755-761.
[15]	WANG Meng, SHEN Xuejing, LIU Jia, SHANG Lulu, ZHANG Mo. Probe-based label-free SERS for identification of breast cancer-induced serum metabolic profiles in patients [J]. Basic & Clinical Medicine, 2025, 45(5): 651-657.

Application of tumor markers in breast cancer diagnosis and prognosis

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments